| Overview |
| bsm-90327r-50µL |
| Src Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human SRC |
| 1-69/536 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 6714 |
| P12931 |
| SRC Proto-Oncogene Non-Receptor Tyrosine Kinase; SRC1; ASV; V-Src Avian Sarcoma (Schmidt-Ruppin A-2) Viral Oncogene Homolog; Proto-Oncogene Tyrosine-Protein Kinase Src; Proto-Oncogene C-Src; EC 2.7.10.2; P60-Src; C-Src; Protooncogene SRC Rous Sarcoma; Tyrosine Protein Kinase SRC-1; Tyrosine Kinase Pp60c-Src; Pp60c-Src; EC 2.7.10; C-SRC; THC6 |
| Cell Line: HT-1080 Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |